More than a decade of experience and still no consensus: controversies in iron therapy.
Besarab
Anatole
A
Division of Nephrology and Hypertension, Henry Ford Hospital, 2799 West Grand Boulevard., Detroit, MI 48202, USA. abesarab@ghsrenal.com
D018798:Anemia, Iron-Deficiency / Q000188:drug therapy* / Q000209:etiology; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000627:therapeutic use*; D006397:Hematinics / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D058085:Iron Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011787:Quality of Health Care; D011994:Recombinant Proteins; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000628:therapy; D016896:Treatment Outcome
D006397:Hematinics; D058085:Iron Compounds; D011994:Recombinant Proteins; D004921:Erythropoietin